Clinical Trials Directory

Trials / Conditions / Heart Decompensation

Heart Decompensation

29 registered clinical trials studyying Heart Decompensation — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingSocial Prescribing to Improve Adherence and Outcomes in Women With Heart Failure
NCT06628973
McGill University Health Centre/Research Institute of the McGill University Health CentreN/A
Enrolling By InvitationCOR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Usi
NCT06763549
Peerbridge Health, Inc—
RecruitingAcquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients with Ethyltoxic Liver Cirrh
NCT06814990
Stephanie GrägerN/A
CompletedMultiparametric Assessment of Cardiac Congestion in Outpatient Worsening Heart Failure
NCT05747820
Corteria Pharmaceuticals—
TerminatedRAndomized Controlled Trial of a Multiple INtervention proGram to Decrease Heart Failure Rehospitalization
NCT04703504
French Cardiology SocietyN/A
UnknownComparison of PEEP in Acute Decompensated Heart Failure
NCT04853563
Asan Medical CenterN/A
CompletedEvaluating the Adherence Improving Self-Management Strategy Intervention in Chronic Heart Failure Patients
NCT04698954
Radboud University Medical CenterN/A
TerminatedInterest of the Smartphone Application "MonCœur" in the Follow-up of Patients With Heart Failure
NCT04198779
French Cardiology SocietyN/A
CompletedAn Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With H
NCT03730961
Bristol-Myers SquibbPhase 2
CompletedAn Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of
NCT03515980
Bristol-Myers SquibbPhase 1
WithdrawnStudy of the Sudden Heart Failure Participant Population in the US
NCT03566264
Bristol-Myers Squibb—
WithdrawnShort-term Efficacy of Furosemide, Isosorbide Dinitrate and Their Combination in ADHF
NCT02649998
Chinese University of Hong KongN/A
UnknownSkeletal Muscles in Acute Heart Failure
NCT03102164
Wroclaw University of Health and Sport Sciences—
UnknownPilot Study for the Evaluation of the Safety and Performance of the RenaSense System in Hospitalized Acute Dec
NCT02324400
Nephera Ltd.Phase 1 / Phase 2
UnknownEarly-start Exercise Training in Subacute Heart Failure
NCT02051985
Fondazione Salvatore MaugeriN/A
TerminatedPronostic Value of Endothelial Dysfunction in Heart Failure
NCT02859636
Centre Hospitalier Universitaire de Besancon—
CompletedBig Data to Assess the Healthcare and Health Outcomes Burden of Acute Coronary Syndromes Complicated With Hear
NCT06255418
Hospital Universitari de Bellvitge—
TerminatedA Phase IIb Study to Investigate the Efficacy and Tolerability of Cinaciguat (150 µg/h, 100 µg/h, 50 µg/h) Giv
NCT01064037
BayerPhase 2
CompletedTreating Congestive Heart Failure Using a Device to Remove Cholesterol
NCT00510601
Patrick Moriarty, MD, FACP, FACCEARLY_Phase 1
CompletedA Study Testing the Effectiveness of Nesiritide in Patients With Acute Decompensated Heart Failure
NCT00475852
Scios, Inc.Phase 3
CompletedAn Open-label, One-arm, Study to Evaluate the Hemodynamic Changes and Safety of Nesiritide for Acute Decompens
NCT00813202
Xian-Janssen Pharmaceutical Ltd.Phase 3
WithdrawnEffects of Nesiritide in Pediatric Patients With Heart Failure
NCT00166010
Emory UniversityN/A
CompletedRegistry for Acute Decompensated Heart Failure Patients Admitted to the ER
NCT00364325
Scios, Inc.—
CompletedEvaluation of the Effects of Carperitide in Patients With Congestive Heart Failure
NCT00259038
Daiichi SankyoPhase 2
CompletedLongitudinal Registry for Advanced Heart Failure Patients
NCT00364416
Scios, Inc.—
CompletedRegistry for Acute Decompensated Heart Failure Patients
NCT00366639
Scios, Inc.—
CompletedA Study to Develop Additional Safety and Clinical Experience With NATRECOR hBNP (Nesiritide) in the Treatment
NCT00271557
Scios, Inc.Phase 3
CompletedA Study of Two Doses of Intravenous NATRECOR hBNP (Nesiritide) in Patients With Worsening Congestive Heart Fai
NCT00288730
Scios, Inc.Phase 3
No Longer AvailableLevosimendan Compassionate Use in Pediatric Patients With Advanced Decompensated Heart Failure
NCT02973620
Tenax Therapeutics, Inc.—